BBC vs. VCLN
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and VCLN (Virtus Duff & Phelps Clean Energy ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while VCLN is a Sustainable fund actively managed by Virtus. BBC is passively managed, while VCLN is actively managed. Over the past 5 years, BBC returned 2.55%/yr vs 2.82%/yr for VCLN. Their 0.45 correlation means their historical movements had little consistent relationship. BBC charges 0.79%/yr vs 0.59%/yr for VCLN.
Performance
BBC vs. VCLN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 27.03% return, which is significantly higher than VCLN's 9.55% return.
BBC
- 1D
- 0.50%
- 1M
- -7.22%
- 6M
- 16.85%
- YTD
- 27.03%
- 1Y
- 132.20%
- 3Y*
- 29.78%
- 5Y*
- 2.55%
- 10Y*
- 9.38%
- ALL TIME*
- 6.30%
VCLN
- 1D
- 1.23%
- 1M
- -6.44%
- 6M
- -1.07%
- YTD
- 9.55%
- 1Y
- 37.73%
- 3Y*
- 14.01%
- 5Y*
- 2.82%
- 10Y*
- —
- ALL TIME*
- 2.77%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $614.18K | $1.46M | $1.24M | |
| $16.61K | $16.57K | $32.94K |
BBC vs. VCLN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 27.03% | 63.77% | -1.11% | -1.80% | -35.13% | -13.62% |
VCLN Virtus Duff & Phelps Clean Energy ETF | 9.55% | 55.75% | -6.69% | -17.54% | -7.87% | -5.21% |
Correlation
The correlation between BBC and VCLN is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.35 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.45 |
Correlation (All Time) Calculated using the full available price history since Aug 4, 2021 | 0.45 |
Over the past year, the correlation between BBC and VCLN has dropped to 0.23 - well below their long-term average of 0.45, suggesting their price drivers have been diverging.
BBC vs. VCLN - Sectors Allocation Comparison
Sectors
BBC
VCLN
Healthcare
-
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
BBC
VCLN
-
Financial Services
BBC
VCLN
-
Basic Materials
BBC
-
VCLN
-
Communication Services
BBC
-
VCLN
-
Consumer Cyclical
BBC
-
VCLN
-
Consumer Defensive
BBC
-
VCLN
-
Energy
BBC
-
VCLN
Industrials
BBC
-
VCLN
Real Estate
BBC
-
VCLN
-
Technology
BBC
-
VCLN
Utilities
BBC
-
VCLN
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. VCLN — Risk / Return Rank
BBC
VCLN
BBC vs. VCLN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Duff & Phelps Clean Energy ETF (VCLN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | VCLN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.45 | ||
| Sortino ratioReturn per unit of downside risk | +2.30 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.21 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 8.81 | 1.43 | +7.38 |
| Martin ratioReturn relative to average drawdown | 23.93 | 4.99 | +18.94 |
Loading charts...
Drawdowns
BBC vs. VCLN - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than VCLN's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for BBC and VCLN.
Loading charts...
Drawdown Indicators
| BBC | VCLN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -45.66% | -31.19% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -26.50% | +11.40% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -26.50% | -27.95% |
Max Drawdown (5Y)Largest decline over 5 years | -70.92% | -45.66% | -25.26% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -18.46% | -22.19% | +3.73% |
Average DrawdownAverage peak-to-trough decline | -36.87% | -23.80% | -13.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.55% | 7.59% | -2.04% |
Volatility
BBC vs. VCLN - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Duff & Phelps Clean Energy ETF (VCLN) have volatilities of 10.19% and 9.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | VCLN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.19% | 9.91% | +0.28% |
Volatility (6M)Calculated over the trailing 6-month period | 26.25% | 23.08% | +3.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.52% | 31.79% | +4.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.61% | 27.79% | +11.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.72% | 27.79% | +9.93% |
BBC vs. VCLN - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than VCLN's 0.59% expense ratio.
Dividends
BBC vs. VCLN - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.34%, less than VCLN's 1.91% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.34% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
VCLN Virtus Duff & Phelps Clean Energy ETF | 1.91% | 2.01% | 1.16% | 1.14% | 0.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and VCLN have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.19%) compared to VCLN (9.91%). In terms of maximum drawdown, BBC dropped -76.85% vs VCLN's -45.66%.
On 5-year performance, VCLN leads with 2.82% vs 2.55% for BBC. On fees, VCLN is cheaper at 0.59% per year. On volatility, VCLN has been the lower-risk option at 9.91%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, VCLN has performed better with a 2.82% return vs 2.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VCLN is cheaper with a 0.59% expense ratio, compared with 0.79% for BBC.
VCLN has the higher dividend yield at 1.91%, compared with 1.34% for BBC.
BBC is categorized as Health & Biotech Equities, while VCLN is Sustainable. Their fees differ too: 0.79% for BBC and 0.59% for VCLN.
BBC currently has the higher Sharpe Ratio (3.65 vs 1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and VCLN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer